In the present study, we investigated the effects of administering recombinant FGF-1 to obesity- or TNF-α-induced insulin resistance mouse models, and our findings indicated that FGF-1 significantly improves insulin resistance and reduces inflammation. The gene discussed is FGF1; the disease is obesity due to melanocortin 4 receptor deficiency.